Lifetime risk and years lived free of total cardiovascular disease

JAMA

Volumn 308, Issue 17, 2012, Pages 1795-1801

  Wilkins, John T ^a   Ning, Hongyan ^a   Berry, Jarett ^b   Zhao, Lihui ^a   Dyer, Alan R ^a   Lloyd Jones, Donald M ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84868320703     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2012.14312     Document Type: Article

References (22)

1. D'Agostino RB Sr, Grundy S, Sullivan LM, Wilson P; CHD Risk Prediction Group. Validation of the Framingham coronary heart disease prediction scores: results of amultiple ethnic groups investigation. JAMA. 2001;286(2):180-187.
2. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001;285(19):2486-2497.
3. Lloyd-Jones DM, Larson MG, Beiser A, Levy D. Lifetime risk of developing coronary heart disease. Lancet. 1999;353(9147):89-92.
4. Lloyd-Jones DM, Leip EP, Larson MG, et al. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation. 2006;113(6):791-798.
5. Lloyd-Jones DM, Larson MG, Leip EP, et al; Framingham Heart Study. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation. 2002;106(24):3068-3072.
6. Berry JD, Dyer A, Cai X, et al. Lifetime risks of cardiovascular disease. N Engl J Med. 2012;366(4):321-329.
7. Dawber TR, Kannel WB, Lyell LP. An approach to longitudinal studies in a community: the Framingham Study. Ann N Y Acad Sci. 1963;107:539-556.
8. Fried LP, Borhani NO, Enright P, et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol. 1991;1(3):263-276.
9. The Atherosclerosis Risk in Communities (ARIC) study, design and objectives: the ARIC investigators. Am J Epidemiol. 1989;129(4):687-702.
10. Stamler J, Dyer AR, Shekelle RB, Neaton JD, Stamler R. Relationship of baseline major risk factors to coronary and all-cause mortality, and to longevity: findings from long-term follow-up of Chicago cohorts. Cardiology. 1993;82(2-3):191-222.
11. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991;265(24):3255-3264.
12. Dawber TR, Meadors GF, Moore FE Jr. Epidemiologic approaches to heart disease: the Framingham study. Am J Public Health. 1951;41(3):279-286.
13. Kannel WB,D'Agostino RB, Silbershatz H, Belanger AJ, Wilson PWF, Levy D. Profile for estimating risk of heart failure. Arch Intern Med. 1999;159(11):1197-1204.
14. Berry JD, Garside DB, Cai X, Dyer AR, Lloyd-Jones DM. Remaining lifetime risks for cardiovascular disease death by risk factor burden at selected ages in black and white men and women [AHA abstract 3666; scientific sessions 2007]. Circulation. 2007;116(16 suppl):832.
15. Vasan RS, Beiser A, Seshadri S, et al. Residual lifetime risk for developing hypertension in middle-aged women and men: the Framingham Heart Study. JAMA. 2002;287(8):1003-1010.
16. Berry JD, Liu K, Folsom AR, et al. Prevalence and progression of subclinical atherosclerosis in younger adults with low short-term but high lifetime estimated risk for cardiovascular disease: the coronary artery risk development in young adults study and multiethnic study of atherosclerosis. Circulation. 2009;119(3):382-389.
17. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation. 2002;106(25):3143-3421. http://http://circ.ahajournals.org/content/ 106/25/3143.full.pdf+html.
18. National Heart, Lung, and Blood Institute. Clinilcal Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Bethesda, MD: National Institutes of Health; 1989.
19. Irwin J. The standard error of an estimate of expectation of life, with special reference to expectation of tumourless life in experiments with mice. J Hyg (Lond). 1949;47(2):188-189.
20. Karrison TG. Use of Irwin's restricted mean as an index for comparing survival in different treatment groups-interpretation and power considerations. Control Clin Trials. 1997;18(2):151-167.
21. Fries JF. Aging, natural death, and the compression of morbidity. N Engl J Med. 1980;303 (3):130-135.
22. Lloyd-Jones DM, Dyer AR, Wang R, Daviglus ML, Greenland P. Risk factor burden in middle age and lifetime risks for cardiovascular and noncardiovascular death (Chicago Heart Association Detection Project in Industry). Am J Cardiol. 2007;99(4):535-540.